Immunologic Research

, Volume 55, Issue 1, pp 10–21

Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus

Immunology in Colorado

DOI: 10.1007/s12026-012-8345-z

Cite this article as:
Giles, B.M. & Boackle, S.A. Immunol Res (2013) 55: 10. doi:10.1007/s12026-012-8345-z


Systemic lupus erythematosus is a severe autoimmune disease that affects multiple organ systems resulting in diverse symptoms and outcomes. It is characterized by antibody production to a variety of self-antigens, but it is specifically associated with those against anti-dsDNA. Anti-dsDNA antibodies are present before the onset of clinical disease and are associated with severe manifestations of lupus such as glomerulonephritis. Their levels fluctuate with changes in disease activity and, in combination with the levels of complement proteins C3 and C4, are strong indicators of disease flare and treatment response in patients with lupus. The decreased complement levels that are noted during flares of lupus activity are believed to be secondary to increased autoantibody production and immune complex formation that results in tissue damage; however, recent data suggest that complement activation can also drive development of these pathogenic autoantibodies. This review will explore the various roles of complement in the development and pathogenesis of anti-dsDNA antibodies.


SLE Autoantibodies Anti-dsDNA antibodies Complement Clearance 

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Rheumatology, Departments of Medicine and ImmunologyUniversity of Colorado School of MedicineAuroraUSA

Personalised recommendations